The landscape of actionable genomic alterations in lung adenocarcinomas in India
Lung adenocarcinoma (LUAD), the most prevalent form of non-small cell lung cancer (NSCLC), remains a leading cause of cancer-related death globally, including in India, with a 5-year survival rate below 10%.Despite these grim statistics, recent advances in the use of next-generation sequencing (NGS) for identifying genetic alterations and the emerg